Synonyms: AZD 8186 | AZD-8186
Compound class:
Synthetic organic
Comment: AZD8186 is a selective inhibitor of PI3Kβ- and δ-mediated AKT signalling [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
AZD8186 in combination with the anti-androgenic drug abiraterone, is being evaluated in Phase 1 clinical trial as a potential treatment for prostate cancer. The two compounds block complementary molecular pathways in prostate cancer, providing synergistic activity. A second Phase 1 study is determining efficacy of AZD8186 plus docetaxel in advanced breast cancer. Click here to link to ClinicalTrials.gov's full list of AZD8186 trials. |